We blend state-of-the-art technology, deep therapeutic knowledge, and a client-focused approach to turn your ambitious goals into achievements.
At Quanticate, we have helped our customers solve their specific dermatology trial challenges, such as recruitment and retention of a diverse patient population, the subjective nature of assessing skin conditions, the variability in disease presentation, and the impact of environmental factors. Ethical considerations, particularly for cosmetic conditions, along with technological, regulatory, and funding challenges, further complicate the execution and interpretation of these trials, which is why our support as a specialist CRO with 3 decades of experience as a leading biometric Clinical Research Organization (CRO) is beneficial.
We’re experts in providing clinical data management, biostatistics, statistical programming and medical writing services for dermatological trials.
Conducting clinical research studies in dermatology poses several unique challenges. Addressing these challenges requires careful planning, robust study design, and innovative approaches to data collection and analysis. Incorporating these solutions, a biometric CRO can significantly address the inherent challenges in dermatology clinical research, enhancing the quality, reliability, and applicability of study results.
Here are the top challenges often encountered, and how a biometric CRO can provide solutions you need:
Recruiting enough participants who meet the specific criteria for dermatological studies can be difficult. Moreover, retaining them throughout the study is challenging, as treatment regimens can be long and require significant commitment. Through early consultation, a biometrics CRO can advise on study designs that reduce the number of subjects needed, reducing the challenges of recruitment and retention, and ensure an overall more efficient and optimal design of a study.
Dermatological conditions often vary greatly in their presentation among different patients. This variability can complicate the assessment of treatment efficacy and the generalization of study results. By utilizing sophisticated statistical analysis , a biometric CRO can better handle the variability in disease presentation, allowing for more accurate assessment of treatment efficacy across diverse patient populations.
Many dermatological studies rely on subjective assessments, such as patient-reported outcomes or visual scoring by clinicians. This can introduce variability and potential bias in results. To reduce variability and bias, a biometric CRO can advise on ways to standardise the assessment as much as possible, reducing the variability. They can also use advanced statistical methods to account for and minimize subjective biases in data analysis.
The placebo effect can be particularly strong in dermatological studies, as patients might perceive an improvement based on non-specific factors like moisturization or the mere act of receiving some form of treatment. By designing sophisticated control groups and using advanced statistical methods to isolate and understand the placebo effect, a biometric CRO can help in distinguishing true treatment effects from placebo responses.
Ethical considerations, especially in studies involving invasive procedures or experimental treatments, are paramount. Informed consent and the potential for side effects need to be carefully managed. A biometric CRO with experience in dermatology studies can support DMCs or safety review boards to monitor safety data and ensure rigorous ethical standards are maintained.
Different skin types and colours can respond differently to treatments, making it challenging to develop universally effective therapies. This diversity must be considered in study design and analysis. Leveraging their expertise in diverse population studies, a biometric CRO can ensure that study designs are inclusive, and analyses are stratified to account for variations in skin colour and type, leading to more universally applicable results.
Ensuring that participants adhere to the treatment regimen, especially when it involves topical applications or lifestyle changes, can be difficult. A biometrics CRO can ensure that treatment compliance is accurately assessed and included with the analysis of the study data.
Some skin conditions require long-term follow-up to adequately assess treatment efficacy and side effects, which can extend the duration and cost of studies. Biometric CROs can advise on smart study designs and minimum data requirements for robust analysis, reducing the need for frequent in-person visits and making long-term follow-up more feasible and less burdensome for participants.
Keeping pace with rapid advancements in technology and methodology, such as genetic analysis and digital imaging, requires constant updating of study protocols and training for researchers. With their focus on staying at the forefront of technological and methodological advances, a biometric CRO can seamlessly integrate the latest innovations in genetic analysis and digital imaging into study protocols, ensuring the research remains cutting-edge.
As a trusted CRO partner for dermatology studies, we have successfully supported trials across the following indications:
© 2024 Quanticate